SCHEMBL22446829

SCHEMBL22446829

C[C@@H](O)[C@@H](C)C(=O)OCC1OC(OC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TLR4 O00206 1/20 0.47
▸ PRKD3 O94806 1/20 0.47
▸ PRKCG P05129 1/20 0.47
▸ PRKCB P05771 1/20 0.47
▸ PRKCA P17252 1/20 0.47
▸ PRKCH P24723 1/20 0.47
▸ PRKCI P41743 1/20 0.47
▸ PRKCE Q02156 1/20 0.47
▸ PRKCQ Q04759 1/20 0.47
▸ PRKCZ Q05513 1/20 0.47
▸ PRKCD Q05655 1/20 0.47
▸ PRKD1 Q15139 1/20 0.47
▸ PTPN1 P18031 2/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ KDR P35968 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ XDH P47989 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18506718 0.86 PRKD3 (0.40) PRKD3PRKCGPRKCBPRKCAPRKCH
SCHEMBL22446825 0.83 TLR4 (0.41) TLR4PRKD3PRKCGPRKCBPRKCA
SCHEMBL19273656 0.83 PRKD3 (0.45) TLR4PRKD3PRKCGPRKCBPRKCA
SCHEMBL21943693 0.81 TLR4 (0.49) TLR4PRKD3PRKCGPRKCBPRKCA
SCHEMBL19961526 0.81 TLR4 (0.49) TLR4PRKD3PRKCGPRKCBPRKCA
SCHEMBL21944328 0.81 TLR4 (0.49) TLR4PRKD3PRKCGPRKCBPRKCA
SCHEMBL16351450 0.81 TLR4 (0.49) TLR4PRKD3PRKCGPRKCBPRKCA
SCHEMBL16361991 0.81 TLR4 (0.49) TLR4PRKD3PRKCGPRKCBPRKCA
SCHEMBL19958445 0.81 TLR4 (0.49) TLR4PRKD3PRKCGPRKCBPRKCA
SCHEMBL17853226 0.81 TLR4 (0.49) TLR4PRKD3PRKCGPRKCBPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10782293-B2 Compositions and methods DIAGNOSTIG LTD (GB) 2020-09-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10782293-B2 Compositions and methods CD14, CD63, LY96 TLR4 870/4885PRKD3 4455/4885PRKCG 3113/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback